Press Releases

Full suite of functionality delivers advanced instrument flight procedure design capabilitiesOTTAWA, ON, June 12, 2026 /CNW/ - 49North, a wholly owned subsidiary of MDA Space Ltd. (TSX:MDA) (NYSE:MDA), today announced a significant refresh of its Global Procedure Designer (GPD), an established and operationally proven expert software tool for the design and sustainment of instrument flight procedures (IFP), updated to align with the latest regulatory criteria and data standards. GPD is an advanced solution supporting procedure design in accordance with industry regulations – ICAO PANS-OPS, FAA TERPS, Transport Canada TP308, and

Torrance, California, June 12, 2026 (GLOBE NEWSWIRE) -- OFA Group (NASDAQ:OFAL) ("OFA" or the "Company") today announced that it has received notice from the Nasdaq Listing Qualifications Department granting the Company an additional 180-calendar-day period, through December 7, 2026, to regain compliance with the minimum $1.00 bid price per share requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq's determination to grant the second compliance period was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the bid price requirement being the

Issued on behalf of GT Biopharma, Inc. Natural killer cells were long overshadowed by T-cell therapies. Now a growing field is trying to unleash them — with the promise of off-the-shelf, lower-toxicity treatments for cancers that have resisted everything else. SAN FRANCISCO, June 12, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — The last decade of cancer immunotherapy was written largely in the language of T cells. Checkpoint inhibitors unleashed them; CAR-T therapies re-engineered them and produced some of the most dramatic remissions modern medicine has ever recorded. But T-cell therapies also carry hard limits: they can be brutally toxic, they are often manufactured one p

BEIJING, June 12, 2026 (GLOBE NEWSWIRE) -- KE Holdings Inc. ("Beike" or the "Company") (NYSE:BEKE, HKEX: 2423)), a leading integrated online and offline platform for housing transactions and services, today announced that each of the proposed resolutions submitted for shareholders' approval (the "Proposed Resolutions") as set forth in the notice of annual general meeting dated April 24, 2026 has been adopted at the meeting held in Beijing, China today. After the adoption of the Proposed Resolutions, all corporate authorizations and actions contemplated thereunder were approved, including, among other things, that (i) the Company's existing memorandum and articles of association are amende

Company earns national recognition for employee culture, inclusion, and investor communications leadership Tanger® (NYSE:SKT), a leading owner and operator of outlet and other open-air retail shopping destinations, has been recognized with two national awards highlighting its commitment to workplace culture and investor communications excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612684684/en/Tanger has been recognized as one of "America's Greatest Midsized Workplaces" 2026 by Newsweek and market-data research firm Plant-A Insights Group. "We believe strong culture and clear communication go hand in hand," said

- JAK2 V671F poster presentation showcases potential best-in-class properties, including improved selectivity compared with currently approved JAK inhibitors - - Selective JAK V617F inhibitor, CGT1145, on track for IND in 2026 - WALTHAM, Mass. and BOULDER, Colo., June 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from its novel, potential best-in-class JAK2 V617F mutant-selective inhibitor in a poster presentation at the 2026 European Hematology Association (EHA) Congress taking place in Stockholm, Sweden, June 11-14, 2026. "We'r

Triple Flag Precious Metals Corp. (with its subsidiaries, "Triple Flag" or the "Company") (TSX:TFPM, NYSE:TFPM) announces that its wholly owned subsidiary, Triple Flag International Ltd., has entered into an agreement to acquire a gold stream (the "Stream") on the producing Ravenswood Gold Mine in Queensland, Australia for upfront cash consideration of US$440 million. Unless otherwise indicated, all amounts are expressed in US dollars. "Triple Flag is very pleased to enter into an agreement to acquire a gold stream on the Ravenswood open-pit gold mine in Australia," commented Sheldon Vanderkooy, CEO. "The Ravenswood stream adds immediate cash flow from a large-scale, long-life operation l

Trading Symbol: TSX/NYSE American: SVMVANCOUVER, BC, June 12, 2026 /CNW/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX:SVM) (NYSE:SVM) is pleased to report the results of an updated Technical Report ("Ying 2026 Technical Report" or "Technical Report") titled "NI 43-101 Technical Report Update on the Ying Ag-Pb-Zn-Au Property in Henan Province, People's Republic of China", prepared in accordance with National Instrument 43‑101 Standards of Disclosure for Mineral Projects ("NI 43-101") by AMC Mining Consultants (Canada) Ltd. ("AMC") with a Mineral Reserve and Mineral Resource effective date of December 31, 2025. The Ying 2026 Technical Report covers seven underground mines (nam

For U.S. media and investors onlyDUBLIN, June 12, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced top-line results from the Phase 3 LAGOON trial, conducted by PharmaMar, evaluating Zepzelca® (lurbinectedin) in patients with relapsed (second-line) metastatic small cell lung cancer (SCLC). The trial did not meet its primary endpoint of overall survival (OS) evaluating Zepzelca as monotherapy or in combination with irinotecan compared to investigators' choice of topotecan or irinotecan. No new safety signals were identified with Zepzelca monotherapy or in combination with irinotecan, and the overall safety profiles of the investigational arms were consistent with the

New Directors Bring Deep Automotive Retail, Public Company Leadership and Financial ExpertiseCARMEL, Ind., June 12, 2026 /PRNewswire/ -- OPENLANE, Inc. (NYSE:OPLN), a leading operator of digital marketplaces for wholesale used vehicles, announces the appointment of Kelly Tuminelli and David Hult to its Board of Directors. Together, Tuminelli and Hult bring extensive public company leadership experience, deep operational and financial expertise, and complementary records of driving growth and value for both customers and stockholders. "We are delighted to welcome Kelly and David to our Board and look forward to drawing on their

Collaboration to Bring Increased Motion-Enhanced Content to Ultra-Premium Large Format Cinematic Experiences GloballyLOS ANGELES, June 12, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ:PXLW) ("Pixelworks" or the "Company"), a provider of innovative cinematic and enhanced visualization solutions, today announced a partnership with China Film CINITY Co., Ltd. ("CINITY") to bring advanced TrueCut Motion grading technology to CINITY's premium large format theaters. Together with its endorsement of TrueCut Motion technology, CINITY is prioritizing the screening of TrueCut Motion-enhanced versions of tent pole movies across its premium large format auditoriums in order to give audiences the most v

As Cunard celebrates America's 250th anniversary, travelers can enter for a chance to sail aboard the world's only ocean liner for an incredible milestone crossingVALENCIA, Calif., June 12, 2026 /CNW/ -- As Queen Mary 2 prepares to join Sail4th 250 this July – celebrating America's 250th anniversary in New York Harbor – Cunard is inviting travelers to become part of its next historic milestone at sea. The British luxury cruise brand has launched a sweepstakes* to celebrate Queen Mary 2's historic 450th Transatlantic Crossing this November – a voyage that continues Cunard's enduring legacy of connecting the United Kingdom and the United States through ocean travel.

Initiates Process to Terminate Advisory Agreement with Ashford and Its Affiliates in Order to Eliminate Relationship with Ashford and Create Its Own Management Team and New BoardPlans Near-Total Reconstitution of the Board, Including Five New Independent Directors, an Independent Chair, and President and CEO Richard Stockton Continuing His DirectorshipDALLAS, June 12, 2026 /PRNewswire/ -- Braemar Hotels & Resorts Inc. (NYSE:BHR) ("Braemar" or the "Company") today announced a series of actions designed to simplify its corporate structure, reduce costs, enhance governance and position the Company for long-term profitability and value creation. Following the conclusion of a lengthy strategic re

Issued on behalf of Starfighters Space, Inc.The sector's defining company is trading on the open market for the first time. A frontier that was private for a generation is now, finally, everyone's to own.Baystreet.ca News CommentaryCAPE CANAVERAL, Fla., June 12, 2026 /CNW/ -- Some market days are remembered less for what a stock did than for what they signified. As reported, today is one of them: SpaceX is set to begin trading publicly on NASDAQ under the ticker SPCX, ending a long era in which the most consequential company in the modern space age remained beyond the reach of public investors. Whatever the first day's price action, the deeper event is structural — the orbital economy now ha

BERKELEY, CA, June 12, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (NASDAQ:PFSA), a digital health company pioneering next-generation biosensing technologies, today announces that it has submitted its response package to questions received from its European Notified Body, GMED, following the successful completion of the Stage 1 and Stage 2 quality system and technical documentation assessments conducted by GMED as part of the MDR conformity assessment process for the Lumee® Oxygen Platform. The response package included updates across multiple aspects of the MDR submission, including technical documentation, quality system evidence, clinical evaluation activities, and supporting validation in

Momentus Inc. (NASDAQ:MNTS) ("Momentus" or the "Company") a leading U.S. commercial space firm specializing in satellite solutions, in-space transportation, and orbital infrastructure, today announced that it has entered into securities purchase agreements with new and existing long term institutional investors for the purchase and sale of 1,851,852 shares of its common stock in a registered direct offering priced at-the-market under Nasdaq rules (the "Offering"). The gross proceeds from the Offering are expected to be approximately $25 million, before deducting placement agent fees and other estimated Offering expenses. The closing of the Offering is expected to occur on or about June 15

Redfin reports the massive IPO would create enough wealth for SpaceX employees to buy roughly 40% of all the homes in San Antonio, one of the closest major metros to where the company is headquartered. Or they could buy every single home in McAllen, located just 80 miles away from SpaceX headquarters. Alternatively, they could buy 5% of all homes in the Los Angeles metro, where the company was founded.With the wealth created through SpaceX's massive IPO, current and former employees could hypothetically pool their money to buy an estimated 40% of all homes in San Antonio, according to a new report from Redfin, the real estate brokerage powered by Rocket. San Antonio is the closest major U.S.

Saudi Arabia Emerges as a Global Biotech Investment Hub Under Vision 2030 Senior Saudi Government, Investment and Healthcare Leaders to Attend the CEL-SCI / Amarox Signing & Opening Ceremonies Strategic Agreement Marks Important Step Toward Commercialization of Multikine® in One of the Middle East's Fastest-Growing Healthcare Markets CEL-SCI Corporation (NYSE:CVM) today announced it will participate in a formal signing ceremony with Saudi Amarox ("Amarox") during the BIO International Convention 2026 in San Diego, California. The ceremony will mark an important milestone in advancing the previously announced strategic agreement between the companies focused on the commercialization an

-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an updated objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria – -- Bezuclastinib demonstrated a powerful effect on mast cell burden with 91% of patients achieving ≥50% reduction in variant allele frequency and 89% of patients achieving ≥50% reduction in bone marrow mast cells or clearance of aggregates – -- Bezuclastinib continues to demonstrate a favorable safety and tolerability profile – -- APEX NDA to be submitted in June 2026 – WALTHAM, Mass. and BOULDER, Colo., June 12, 2026 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnolo

GRAND RAPIDS, Mich. and HASTINGS, Mich., June 12, 2026 (GLOBE NEWSWIRE) -- Independent Bank Corporation (NASDAQ:IBCP), the parent company of Independent Bank, with total assets of approximately $5.5 billion, and HCB Financial Corp. ("HCB"), the parent company of Highpoint Community Bank, with total assets of approximately $590 million, previously announced the signing of a definitive merger agreement on March 18, 2026 for IBCP to acquire HCB. The proposed transaction has been approved by both the Federal Reserve Bank of Chicago and the Michigan Department of Insurance and Financial Services. A meeting of the HCB shareholders has been scheduled for June 17, 2026 to consider and vote upon